We are live on ! Find out more
FGP

Foyston, Gordon, & Payne Portfolio holdings

AUM $434M
1-Year Est. Return 9.09%
This Fund
S&P 500
This Quarter Est. Return
-3.63%
1 Year Est. Return
+9.09%
3 Year Est. Return
+56.86%
5 Year Est. Return
+84.63%
10 Year Est. Return
+238.52%
AUM
$408M
AUM Growth
-$20.3M
Cap. Flow
+$1.01M
Cap. Flow %
0.25%
Top 10 Hldgs %
41.87%
Holding
67
New
6
Increased
20
Reduced
27
Closed
5

Top Buys

Rank Stock Value
1
TFC icon
Truist Financial
TFC
+$5.22M
2
ZBRA icon
Zebra Technologies
ZBRA
+$4.15M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$4.15M
4
V icon
Visa
V
+$2.82M
5
ROST icon
Ross Stores
ROST
+$2.37M

Top Sells

Rank Stock Value
1
CHRW icon
C.H. Robinson
CHRW
+$3.43M
2
PM icon
Philip Morris
PM
+$2.62M
3
UNH icon
UnitedHealth
UNH
+$2.62M
4
CDW icon
CDW
CDW
+$2.55M
5
BKNG icon
Booking.com
BKNG
+$2.52M

Sector Composition

Rank Sector Weight
1 Technology 23.11%
2 Healthcare 21.38%
3 Industrials 16.48%
4 Financials 14.16%
5 Consumer Staples 10.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LIN icon
26
Linde
LIN
$221B
$5.81M 1.42%
18,197
-890
-5% -$275K
KO icon
27
Coca-Cola
KO
$377B
$5.81M 1.42%
93,745
+25
+0% +$1.52K
BRK.B icon
28
Berkshire Hathaway Class B
BRK.B
$1.1T
$5.76M 1.41%
16,323
META icon
29
Meta Platforms (Facebook)
META
$1.42T
$5.62M 1.38%
25,287
-415
-2% -$104K
ULTA icon
30
Ulta Beauty
ULTA
$22B
$4.84M 1.19%
12,166
-530
-4% -$200K
CME icon
31
CME Group
CME
$96.3B
$4.83M 1.18%
20,283
+1,345
+7% +$316K
TFC icon
32
Truist Financial
TFC
$63.3B
$4.79M 1.17%
+84,565
New +$5.22M
GNTX icon
33
Gentex
GNTX
$4.97B
$4.58M 1.12%
156,930
-50,917
-24% -$1.58M
OTIS icon
34
Otis Worldwide
OTIS
$27.4B
$4.58M 1.12%
59,471
-7,789
-12% -$623K
PFE icon
35
Pfizer
PFE
$143B
$4.43M 1.09%
85,639
-6,639
-7% -$344K
SONY icon
36
Sony
SONY
$137B
$4.39M 1.08%
213,895
-4,370
-2% -$95K
ALSN icon
37
Allison Transmission
ALSN
$9.5B
$4.33M 1.06%
110,288
+12,784
+13% +$503K
BDX icon
38
Becton Dickinson
BDX
$45.6B
$4.26M 1.04%
16,410
+1,489
+10% +$383K
GOOGL icon
39
Alphabet (Google) Class A
GOOGL
$4.36T
$4.25M 1.04%
+30,560
New +$4.15M
AOS icon
40
A.O. Smith
AOS
$8.17B
$4.16M 1.02%
65,126
-9,467
-13% -$689K
RTX icon
41
RTX Corp
RTX
$290B
$4.13M 1.01%
41,675
+10,957
+36% +$1.04M
CPRT icon
42
Copart
CPRT
$27B
$3.97M 0.97%
126,484
-4,180
-3% -$133K
WMT icon
43
Walmart Inc
WMT
$885B
$2.97M 0.73%
59,850
NVS icon
44
Novartis
NVS
$297B
$2.78M 0.68%
31,680
+35
+0.1% +$3.03K
VVV icon
45
Valvoline
VVV
$4.9B
$2.42M 0.59%
76,786
-11,696
-13% -$382K
SNY icon
46
Sanofi
SNY
$103B
$2.31M 0.56%
44,894
-517
-1% -$26.7K
WTW icon
47
Willis Towers Watson
WTW
$31.2B
$2.27M 0.56%
+9,604
New +$2.2M
RELX icon
48
RELX
RELX
$61.8B
$2.1M 0.51%
67,470
-4,834
-7% -$146K
HUM icon
49
Humana
HUM
$43.7B
$2.06M 0.51%
+4,741
New +$1.98M
ABBV icon
50
AbbVie
ABBV
$443B
$1.99M 0.49%
12,242
+42
+0.3% +$6.1K

Similar funds

Foyston, Gordon, & Payne's Q1 2022 Portfolio in Review

As of Q1 2022, Foyston, Gordon, & Payne held 67 positions worth $408M, down 4.7% from $429M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Foyston, Gordon, & Payne's Q1 2022 filing shows 6 new, 20 increased, 27 reduced and 5 closed positions. Its largest new stake was Truist Financial: 84,565 shares worth $4.79M. The largest sale was C.H. Robinson, an estimated $3.43M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Industrials.

  • Foyston, Gordon, & Payne's largest Q1 2022 buy was Truist Financial: 84,565 shares worth $4.79M.
  • Foyston, Gordon, & Payne added most to Zebra Technologies in Q1 2022, an estimated $4.15M increase.
  • Foyston, Gordon, & Payne's biggest Q1 2022 reduction was C.H. Robinson, cutting an estimated $3.43M.
  • Foyston, Gordon, & Payne fully exited CDW in Q1 2022, selling an estimated $2.55M.
  • Foyston, Gordon, & Payne's ten largest holdings make up 42% of its $408M portfolio in Q1 2022.
  • Foyston, Gordon, & Payne opened 6 new positions and closed 5 in Q1 2022.
  • Foyston, Gordon, & Payne's portfolio value fell 4.7% quarter-over-quarter to $408M.

Based on Foyston, Gordon, & Payne's 13F filing for Q1 2022, filed 27 Apr 2022.